4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-011496
Director sold 63,795 shares at $1.37 ($87,399)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahadevia Ankit Director | 2024-02-02 | Sale | −63,795 | $1.37 | $87,399 | 744,997 | D |
| Open-market sales · 63,795 sh · avg $1.37 · $87,399 | |||||||
Loading xslF345X05/ownership.xml…